Newly Published Preclinical Data on Oragenics, Inc.’s Lantibiotic Compound Demonstrates Tolerability and Compartmentalization to the GI Tract May 13, 2019
Oragenics, Inc. Enters into Collaboration with Florida International University to Expand Its Pipeline of Lantibiotics March 27, 2019
Oragenics Inc. to Attend the Roth Capital 31st Annual Growth Conference March 17 - 19, 2019 March 15, 2019
